Characteristics of lipid metabolism dysfunction in hypertensive disorders of pregnancy

Zizhuo Wang1,2, Liangnan Zhang1,2, Xuan Zhou1,2

  • 1National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

PubMed

Insights

Hypertensive disorders of pregnancy (HDP) show altered lipid metabolism, especially fatty acids (FAs), linked to clinical features. MCAM and MAPK pathways may play roles in HDP pathogenesis.

Area of Science:

  • Obstetrics and Gynecology
  • Metabolomics
  • Molecular Biology

Background:

  • Hypertensive disorders of pregnancy (HDP) are major causes of maternal and perinatal morbidity.
  • Lipid metabolism dysfunction is implicated in HDP, but its specific characteristics are unclear.

Purpose of the Study:

  • To investigate lipid metabolism dysfunction in HDP.
  • To identify molecular pathways involved in HDP-related lipid dysregulation.

Main Methods:

  • Full-spectrum metabolomic profiling of blood samples from 30 HDP patients and 30 controls.
  • Targeted metabolic validation in placental tissues.
  • RNA sequencing to analyze gene expression related to lipid metabolism.

Main Results:

  • Significant disruptions in fatty acyl (FA) metabolism observed in HDP patients.
  • Specific FA levels correlated with HDP clinical characteristics.
  • MCAM expression linked to FA metabolism and HDP symptoms; MAPK pathway activation suggested.

Conclusions:

  • Provides insights into lipid metabolism dysfunction in HDP.
  • Delineates potential molecular pathways involving MCAM and MAPK in HDP pathogenesis.
Abstract

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
787
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.8K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
467
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K